Development Agreements in the Pharmaceuticals Industry

227 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Development and Supply Agreement between Evofem Biosciences, Inc. and Pharma 1 Drug Store L.L.C.
Development Agreements
Evofem Biosciences, Inc.
Pharmaceuticals
2025
Master Research and Development Agreement between Expert Systems, Inc. and Trawsfynydd Therapeutics, Inc.
Development Agreements
Onconova Therapeutics, Inc.
Pharmaceuticals
CA
2025
Master Research and Development Agreement between Viriom, Inc. and Trawsfynydd Therapeutics Inc.
Development Agreements
Onconova Therapeutics, Inc.
Pharmaceuticals
CA
2025
First Amendment to Development and Manufacturing Services Agreement between Lonza Sales AG, Lonza AG, and Context Therapeutics Inc.
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2025
Amendment No. 4 to Technical Transfer and Service Agreement between Pacira Limited and Patheon UK Limited
Development Agreements
Pacira Pharmaceuticals, Inc.
Pharmaceuticals
NY
2025
Amendment No. 2 to Technical Transfer and Service Agreement between Pacira Limited and Patheon UK Limited
Development Agreements
Pacira Pharmaceuticals, Inc.
Pharmaceuticals
NY
2025
Amendment No. 2 to Manufacturing and Commercialization Agreement between Corium Innovations, Inc. and Agile Therapeutics, Inc.
Development Agreements
AGILE THERAPEUTICS INC
Pharmaceuticals
2024
Amendment No. 2 to Manufacturing and Commercialization Agreement between Corium Innovations, Inc. and Agile Therapeutics, Inc.
Development Agreements
AGILE THERAPEUTICS INC
Pharmaceuticals
2024
Third Amendment to Development and Commercialization Agreement between Pulmatrix, Inc., Pulmatrix Operating Company, Inc., and Cipla Technologies, LLC
Development Agreements
Pulmatrix, Inc.
Pharmaceuticals
2024
Amendment to Contract Research Agreement between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
Development Agreements
Amphastar Pharma
Pharmaceuticals
2023
Development and Manufacturing Services Agreement between Lonza Sales AG, Lonza AG, and Context Therapeutics Inc.
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Amendment No. 3 to Process Development Agreement and Amendment No. 1 to License, Development, Manufacturing & Marketing Agreement between Tyligand Bioscience (Shanghai) Limited...
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Amendment No. 1 to Manufacturing and Commercialization Agreement between Corium, Inc. and Agile Therapeutics, Inc.
Development Agreements
AGILE THERAPEUTICS INC
Pharmaceuticals
DE
2022
Product Development and Manufacturing Agreement between Manuka Ltd. and Chic Cosmetics Industries 1989 Ltd.
Development Agreements
Artemis Therapeutics, Inc.
Pharmaceuticals
2022
Multi-Unit Development Agreement between Can B Corp and Jameson, LLC dba American Development Partners
Development Agreements
Canbiola, Inc.
Pharmaceuticals
TN
2022
Second Amendment to Development and Commercialization Agreement between Pulmatrix, Inc., Pulmatrix Operating Company, Inc., and Cipla Technologies, LLC
Development Agreements
Pulmatrix, Inc.
Pharmaceuticals
2021
Amendment No. 2 to Process Development Agreement between Tyligand Bioscience (Shanghai) Limited and Context Therapeutics LLC
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Amendment No. 1 to Process Development Agreement between Tyligand Bioscience (Shanghai) Limited and Context Therapeutics LLC
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Process Development Agreement between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Amendment No. 1 to Technology Transfer, Validation and Commercial Fill/Finish Services Agreement between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Amendment No. 5 to Research, Development and Commercialization Agreement between Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics
Development Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Second Amendment to Research, Development and Commercialization Agreement between Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics (January 1, 2006)
Development Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Assay Identification and Milestone Payment Letter Agreement between Zomedica Pharmaceuticals Corp. and Qorvo Biotechnologies, LLC
Development Agreements
Zomedica Pharmaceuticals Corp.
Pharmaceuticals
2020
Joint Development Agreement between RareGen, LLC and Carelife USA Inc. (May 3, 2019)
Development Agreements
Liquidia Corp
Pharmaceuticals
DE
2020
Amendment No. 7 to Research, Development and Commercialization Agreement between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics Incorporated
Development Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Second Amendment to Research, Development and Commercialization Agreement between Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics
Development Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Development Agreement between CNS Pharmaceuticals, Inc. and WPD Pharmaceuticals (March 20, 2020)
Development Agreements
CNS Pharmaceuticals, Inc.
Pharmaceuticals
2020
Development and Royalty Agreement between Voltron Therapeutics, Inc. and Hoth Therapeutics, Inc.
Development Agreements
Hoth Therapeutics, Inc.
Pharmaceuticals
NY
2020
Amendment No. 1 to Development and Commercialization Agreement between Theravance Biopharma Ireland Limited and Mylan Ireland Limited
Development Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2019
Development and Commercialization Agreement between Pulmatrix, Inc. and Cipla Technologies, LLC (April 15, 2019)
Development Agreements
Pulmatrix, Inc.
Pharmaceuticals
CA
2019
Development Agreement Between Mikah Pharma LLC and Elite Laboratories, Inc. Effective December 3, 2018
Development Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
NJ
2019
SmartDose Development Agreement between scPharmaceuticals and West Pharmaceutical Services, Inc.
Development Agreements
scPharmaceuticals Inc.
Pharmaceuticals
2019
Manufacturing Development and Scale-Up Agreement between Liquidia Technologies, Inc. and Chasm Technologies, Inc.
Development Agreements
Liquidia Technologies Inc
Pharmaceuticals
DE
2019
Amendment No. 4 to Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH
Development Agreements
ALDER BIOPHARMACEUTICALS INC
Pharmaceuticals
2019
Amendment No. 1 to Contract Manufacturing Agreement between Alder BioPharmaceuticals, Inc. and Sandoz GmbH
Development Agreements
ALDER BIOPHARMACEUTICALS INC
Pharmaceuticals
2019
Umbrella Development Services Agreement between Patheon UK Limited and Kaleido Biosciences, Inc.
Development Agreements
Kaleido Biosciences, Inc.
Pharmaceuticals
DE
2019
Feasibility Study Quotation Agreement between Kannalife Sciences, Inc. and Catalent Pharma Solutions, LLC for Cannabidiol Softgel Development
Development Agreements
Kannalife Inc
Pharmaceuticals
NJ
2018
Development, Supply and Commercialization Agreement between Amphastar Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc.
Development Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Development, Supply and Commercialization Agreement between Eton Pharmaceuticals, Inc. and [Counterparty]
Development Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Development Agreement between Aesica Queenborough Limited and Opiant Pharmaceuticals Inc. for Nalmefene Hydrochloride Device
Development Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018